SCHEMBL9045181

SCHEMBL9045181

Cc1ccc(-c2c(Cl)ncnc2NS(=O)(=O)c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 5/20 0.59
EDNRB P24530 5/20 0.59
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
TDP1 Q9NUW8 1/20 0.57
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
KIT P10721 2/20 0.46
KDM1A O60341 1/20 0.46
NPY5R Q15761 1/20 0.45
FFAR1 O14842 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNA2 P20248 1/20 0.44
CDK2 P24941 1/20 0.44
CDK7 P50613 1/20 0.44
CCNH P51946 1/20 0.44
CCNA1 P78396 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9045067 0.91 EDNRA (0.70) EDNRAEDNRBMEN1KMT2ATDP1
SCHEMBL9045084 0.91 EDNRA (0.70) EDNRAEDNRBMEN1KMT2ATDP1
SCHEMBL9045052 0.91 MEN1 (0.55) EDNRAEDNRBMEN1KMT2ATDP1
SCHEMBL6785011 0.90 EDNRA (0.67) EDNRAEDNRBMEN1KMT2AALDH1A1
SCHEMBL9046552 0.89 EDNRA (0.57) EDNRAEDNRBMEN1KMT2ATDP1
SCHEMBL9494268 0.88 EDNRA (0.56) EDNRAEDNRBMEN1KMT2ATDP1
SCHEMBL9045149 0.87 NPSR1 (0.51) EDNRAEDNRBMEN1KMT2ATDP1
SCHEMBL9046709 0.87 ALDH1A1 (0.60) EDNRAEDNRBMEN1KMT2AALDH1A1
SCHEMBL9044998 0.86 PTGDR2 (0.52) EDNRAEDNRBMEN1KMT2ATDP1
SCHEMBL7721651 0.85 EDNRA (0.64) EDNRAEDNRBMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed